The long term objectives are to elucidate the function of the erythroid cytoskeletal proteins and to determine the pathological consequences of their absence. A heritable deficiency of ankyrin, Ank1, provides a mouse model for the human disease, Hereditary Spherocytosis. The murine disease manifestations, as in the human, are not limited to red blood cells but involve other tissues, such as brain, where erythroid transcripts are normally localized. For example, humans with Ank1 deficits have neurological symptoms and we have shown that latent degeneration of the cerebellar Purkinje cells in the Ank1 deficient, nb/nb, mice occurs consonant with onset of a tremor. The remarkable diversity of tissue specific and developmentally regulated isoforms suggests alternate and as yet unknown functional roles for ankyrin. Focus here is on the role of specific motifs at the 3' end of Ank1 and on the identification of the Ank1 transcripts in Purkinje cells. Our recent findings target research to the following. (1) A 17.5 kD muscle isoform (skAnk1) with a unique functional membrane anchor has it's own first exon and promoter in the distal end of the Ank1 gene. (2) Two COOH-terminal motifs of Ank1 are expressed in a tissue and developmental specific fashion. (3) Ank1 3'UTR sequences are highly conserved (greater than 70 percent) between mouse and human and vary due to use of alternate sites of polyadenylation.
Specific Aims are to: Determine the function of the skAnk1 isoform and its membrane anchor by deleting the skeletal muscle first exon through homologous recombination in embryonic stem cells (ESC); Determine the functional significance of the alternative COOH-termini by using homologous recombination in ESC to delete the specific exon segments that code for each terminus; Define the functional significance of sequences within the 3'UTR by in situ hybridization and transfection of reporter constructs into cells in culture: and Characterize the process of Purkinje cell degeneration in the nb/nb mice and identify the role of Ank1 proteins in this process.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL029305-19
Application #
6363488
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Thomas, John
Project Start
1983-04-01
Project End
2003-02-28
Budget Start
2001-04-06
Budget End
2002-02-28
Support Year
19
Fiscal Year
2001
Total Cost
$406,185
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Birkenmeier, Connie S; Barker, Jane E (2004) Hereditary haemolytic anaemias: unexpected sequelae of mutations in the genes for erythroid membrane skeletal proteins. J Pathol 204:450-9
Wandersee, Nancy J; Olson, Scott C; Holzhauer, Sandra L et al. (2004) Increased erythrocyte adhesion in mice and humans with hereditary spherocytosis and hereditary elliptocytosis. Blood 103:710-6
Wandersee, Nancy J; Birkenmeier, Connie S; Bodine, David M et al. (2003) Mutations in the murine erythroid alpha-spectrin gene alter spectrin mRNA and protein levels and spectrin incorporation into the red blood cell membrane skeleton. Blood 101:325-30
Wandersee, N J; Lee, J C; Deveau, S A et al. (2001) Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells. Blood 97:3972-5
Wandersee, N J; Roesch, A N; Hamblen, N R et al. (2001) Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis. Blood 97:543-50
Peters, L L; Lane, P W; Andersen, S G et al. (2001) Downeast anemia (dea), a new mouse model of severe nonspherocytic hemolytic anemia caused by hexokinase (HK(1)) deficiency. Blood Cells Mol Dis 27:850-60
Wandersee, N J; Tait, J F; Barker, J E (2000) Erythroid phosphatidyl serine exposure is not predictive of thrombotic risk in mice with hemolytic anemia. Blood Cells Mol Dis 26:75-83
Barker, J E; Deveau, S; Wandersee, N J (2000) Amelioration of severe hereditary spherocytosis in nonablated adult mice by marrow transplantation. Exp Hematol 28:985-92
Dooner, G J; Barker, J E; Gallagher, P G et al. (2000) Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro. Exp Hematol 28:765-74
Wandersee, N J; Birkenmeier, C S; Gifford, E J et al. (2000) Murine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the erythroid alpha-spectrin gene. Hematol J 1:235-42

Showing the most recent 10 out of 34 publications